Trust Investment Advisors Invests $277,000 in Corteva, Inc. $CTVA

Trust Investment Advisors bought a new position in Corteva, Inc. (NYSE:CTVA) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,722 shares of the company’s stock, valued at approximately $277,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Gladwyn Financial Advisors Inc. bought a new position in shares of Corteva during the second quarter valued at $25,000. Curat Global LLC lifted its holdings in shares of Corteva by 93.7% during the second quarter. Curat Global LLC now owns 370 shares of the company’s stock valued at $28,000 after purchasing an additional 179 shares in the last quarter. Maryland Capital Advisors Inc. bought a new position in shares of Corteva during the second quarter valued at $29,000. Valley National Advisers Inc. lifted its holdings in shares of Corteva by 85.9% during the first quarter. Valley National Advisers Inc. now owns 526 shares of the company’s stock valued at $33,000 after purchasing an additional 243 shares in the last quarter. Finally, Richardson Capital Management LLC bought a new position in shares of Corteva during the first quarter valued at $37,000. 81.54% of the stock is owned by institutional investors.

Corteva Stock Performance

Shares of CTVA opened at $63.89 on Tuesday. The company has a quick ratio of 1.23, a current ratio of 1.68 and a debt-to-equity ratio of 0.06. The business has a 50-day simple moving average of $68.36 and a two-hundred day simple moving average of $69.24. The stock has a market cap of $43.39 billion, a price-to-earnings ratio of 31.16, a PEG ratio of 1.46 and a beta of 0.76. Corteva, Inc. has a 52 week low of $53.40 and a 52 week high of $77.41.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $2.20 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.31. The business had revenue of $6.46 billion during the quarter, compared to analysts’ expectations of $6.26 billion. Corteva had a return on equity of 8.68% and a net margin of 8.16%.The business’s quarterly revenue was up 5.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.83 earnings per share. On average, analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CTVA. JPMorgan Chase & Co. raised Corteva from a “neutral” rating to an “overweight” rating and set a $67.00 price target on the stock in a report on Thursday, October 2nd. Citigroup downgraded Corteva from a “buy” rating to a “neutral” rating and lowered their price target for the company from $83.00 to $70.00 in a report on Thursday, October 2nd. Weiss Ratings downgraded Corteva from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, October 8th. The Goldman Sachs Group lowered their target price on Corteva from $85.00 to $77.00 and set a “buy” rating on the stock in a report on Wednesday, October 22nd. Finally, Oppenheimer lowered their target price on Corteva from $87.00 to $75.00 and set an “outperform” rating on the stock in a report on Wednesday, October 22nd. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $79.94.

Insider Buying and Selling

In other Corteva news, EVP Robert D. King sold 37,280 shares of the company’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $74.20, for a total value of $2,766,176.00. Following the completion of the sale, the executive vice president owned 49,262 shares in the company, valued at $3,655,240.40. This represents a 43.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.14% of the stock is currently owned by insiders.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.